Cargando…

Apatinib and temozolomide in children with recurrent ependymoma: A case report

Outcomes remain poor in children with recurrent ependyomams (rEPNs), despite advances in surgery and radiotherapy. Systemic therapeutic options are limited, given the low response to chemotherapy and targeted drugs. There is an urgent need for efective pharmacotherapy. Apatinib is a multitarget tyro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Shuangshuang, Shen, Zhipeng, Li, Juan, Shi, Lei, Zhang, Ni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478300/ https://www.ncbi.nlm.nih.gov/pubmed/36123900 http://dx.doi.org/10.1097/MD.0000000000030529

Ejemplares similares

Apatinib Plus Temozolomide: An Effective Salvage Treatment for Recurrent Glioblastoma
por: Ge, Jingjing, et al.
Publicado: (2021)

Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report
por: Zhao, Mingming, et al.
Publicado: (2022)

Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study
por: Wang, Yong, et al.
Publicado: (2019)

Efficacy of apatinib combined with temozolomide in the treatment of recurrent high‑grade glioma: A meta‑analysis
por: Li, Guanglie, et al.
Publicado: (2023)

Case report of a KIT-mutated melanoma patient with an excellent response to apatinib and temozolomide combination therapy
por: Luo, Cong, et al.
Publicado: (2017)

Radiotherapy with apatinib for recurrence of malignant phyllodes tumor of the breast: A case report
por: Wu, Hong, et al.
Publicado: (2020)

Apatinib suppresses cell growth and metastasis and promotes antitumor activity of temozolomide in glioma
por: Wang, Chao, et al.
Publicado: (2018)

Safety and Efficacy of Apatinib Combined with Temozolomide in Advanced Melanoma Patients after Conventional Treatment Failure()
por: Cui, ChuanLiang, et al.
Publicado: (2018)

Individualized treatment for a case of recurrent ovarian ependymoma
por: Yuan, Zhen, et al.
Publicado: (2018)

Apatinib for the treatment of pulmonary epithelioid hemangioendothelioma: A case report and literature review
por: Zheng, Zhipeng, et al.
Publicado: (2017)

EPEN-37. TREATMENT OUTCOME OF RECURRENT EPENDYMOMA IN CHILDREN IN NORTHERN EGYPT
por: Fadel, Shady, et al.
Publicado: (2020)

A Study Of Efficacy And Safety With Apatinib Or Apatinib Combined With Chemotherapy In Recurrent/advanced Ovarian Cancer Patients
por: Yang, Mi, et al.
Publicado: (2019)

A Case of Recurrent Supratentorial Extraventricular Anaplastic Ependymoma in Adult
por: Seo, Sung-Won, et al.
Publicado: (2019)

Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma
por: Yuan, Shumin, et al.
Publicado: (2022)

Supratentorial ependymomas in children: Analysis of nine cases
por: Alexiou, George A., et al.
Publicado: (2013)

Recurrent Extradural Myxopapillary Ependymoma With Oligometastatic Spread
por: Batich, Kristen A., et al.
Publicado: (2019)

A case report of apatinib in treating osteosarcoma with pulmonary metastases
por: Zhou, Yong, et al.
Publicado: (2017)

A case report of targeted therapy with apatinib in a patient with recurrent high grade glioma
por: Ding, Xiuping, et al.
Publicado: (2018)

Case Report: Low-Dose Apatinib in the Treatment of Intrahepatic Biliary Cystadenoma With Recurrence and Malignant Transformation
por: Yang, Yongguang, et al.
Publicado: (2021)

Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma
por: Lin, Hao, et al.
Publicado: (2023)

Case Report and Review of Literature: Camrelizumab Combined with Fuzuloparib and Apatinib for Platinum-Resistant Recurrent Ovarian Cancer
por: Wu, Yawen, et al.
Publicado: (2022)

Multiline treatment combining apatinib with toptecan for platinum-resistant recurrent ovarian cancer patients: a report of three cases
por: Cheng, Yuan, et al.
Publicado: (2018)

Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series
por: Zhang, Honghong, et al.
Publicado: (2017)

Case Report: Favorable Response to the Tyrosine Kinase Inhibitor Apatinib in Recurrent Merkel Cell Carcinoma
por: Feng, Yiyi, et al.
Publicado: (2021)

Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma
por: Tabori, U, et al.
Publicado: (2008)

Dorsal cervical approach for recurrent intradural anaplastic ependymoma
por: Laws, Maxwell T., et al.
Publicado: (2023)

Temozolomide and oral etoposide in children with recurrent malignant brain tumors
por: Ruggiero, Antonio, et al.
Publicado: (2020)

Efficacy and Safety of Apatinib in the Treatment of Postoperative Recurrence of Fibrosarcoma
por: Ma, Huiwen, et al.
Publicado: (2020)

Ependymomas
por: Bertero, Luca, et al.
Publicado: (2022)

Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression
por: Wang, Zhongyu, et al.
Publicado: (2021)

Role of Evaluating MGMT Status and 1p36 Deletion in Radiosurgery-Induced Anaplastic Ependymoma That Rapidly and Completely Resolved by Temozolomide Alone: Case Report and Review of the Literature
por: Hirono, Seiichiro, et al.
Publicado: (2015)

Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option
por: Zhang, Hong-Hong, et al.
Publicado: (2022)

EPEN-05. CLINICAL AND GENETIC EVOLUTION OF EPENDYMOMA EXPOSED FROM A MULTI-RECURRENCE GIRL CASE
por: Chen, Zhong-ping, et al.
Publicado: (2020)

CS-11 PITUITARY EPENDYMOMA: A CASE REPORT
por: Fukami, Tadateru, et al.
Publicado: (2019)

Anaplastic myxopapillary ependymoma of the sacrum: A case report
por: Rahimizadeh, Abolfazl, et al.
Publicado: (2021)

Phase II study of everolimus for recurrent or progressive pediatric ependymoma
por: Bowers, Daniel C, et al.
Publicado: (2023)

Apatinib-treated advanced medullary thyroid carcinoma: a case report
por: Chen, Kan, et al.
Publicado: (2018)

Sacrococcygeal myxopapillary ependymoma with anaplastic ependymoma component in an infant
por: Chakraborti, Shrijeet, et al.
Publicado: (2012)

PARP inhibition utilized in combination therapy with Olaparib‐Temozolomide to achieve disease stabilization in a rare case of BRCA1‐mutant, metastatic myxopapillary ependymoma
por: Mahalingam, Preethika, et al.
Publicado: (2023)

Primary mediastinal ependymoma: A case report and literature review
por: Ye, Wei-biao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s0tk0bhllep6tpj2ae6tjjduca